BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//The European School of Multimodality Imaging & Therapy (ESMIT) - ECPv6.15.11//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://esmit.eanm.org
X-WR-CALDESC:Events for The European School of Multimodality Imaging & Therapy (ESMIT)
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:Europe/Vienna
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20250330T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20251026T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20260329T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20261025T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20270328T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20271031T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=Europe/Vienna:20260508T133000
DTEND;TZID=Europe/Vienna:20260508T143000
DTSTAMP:20260613T065804
CREATED:20251004T070000Z
LAST-MODIFIED:20260507T110508Z
UID:2851-1778247000-1778250600@esmit.eanm.org
SUMMARY:Dosimetry in Clinical Trials
DESCRIPTION:Targeted Radionuclide Therapy (TRT) is an expanding field of cancer treatment in which radiopharmaceuticals—comprising a radionuclide linked to a tumour-targeting biological vector—are administered to deliver cytotoxic radiation doses selectively to malignant tissues. The growing development of theragnostic agents\, enabling both imaging and therapy\, has strengthened the rationale for a patient-specific treatment approach. \n\n\n\nIn clinical trials\, dosimetry plays a phase-dependent role: in early-phase studies\, it is essential for establishing safety profiles and dose- toxicity correlations for organs at risk\, while in later phases it contributes to efficacy assessment\, treatment comparison\, and long-term outcome evaluation. This webinar will provide an overview of the regulatory and methodological framework for integrating dosimetry into TRT clinical trials\, with particular emphasis on its role in assessing safety\, efficacy\, and effects. Examples from recent and ongoing trials will be presented to illustrate how dosimetric data can inform trial design\, support treatment personalization\, and ultimately facilitate the transition toward dosimetry-guided therapeutic strategies. \n\n\n\n \n\n\n\n \n\n\n\n \n\n\n\n\n\n\n\nRegister nowEnrol in the live webinar now for free! Register now\n\n\n\n\n\n\n\n \n\n\n\n \n\n\n\nLearning Objectives\n\n\n\n \n\n\n\n\nProvide an overview of the key elements involved in the design of clinical TRT trials.\n\n\n\nExplain the rationale and advantages of implementing dosimetry in TRT clinical trials.\n\n\n\nIdentify key factors for designing dosimetry protocols tailored to the specific radiopharmaceutical and the phase of the clinical trial.”\n\n\n\n\n \n\n\n\n \n\n\n\nTarget Audience\n\n\n\n \n\n\n\n\nThis webinar is intended for professionals involved in TRT\, mainly nuclear medicine physicians\,  technologists and medical physicists.\n\n\n\n\n \n\n\n\n \n\n\n\nFaculty\n\n\n\n \n\n\n\n\n\nMarta CremonesiSpeaker \n\n\n\n\n\nCaroline StokkeSpeaker \n\n\n\n\n\nAnna SarnelliModerator \n\n\n\n\n\n\n\n\n\nEvent Overview
URL:https://esmit.eanm.org/event/dosimetry-in-clinical-trials/
CATEGORIES:Live Webinars
END:VEVENT
END:VCALENDAR